Premium Industrial News

China's Pharma Companies Face Fiscal Challenges for R&D Projects

China's Pharma Companies Face Fiscal Challenges for R&D Projects

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 185 Words
Attachment: China RD pharma 0621

BEIJING--June 8, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--In the last 10 years, the average return on investment (ROI) in China's pharmaceutical research and development (R&D) market has declined, which creates an obstacle for China's small- and medium-sized developers of patterned drugs.

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?